Glycol chitosan/oxidized hyaluronic acid hydrogel film for topical ocular delivery of dexamethasone and levofloxacin

被引:63
作者
Bao, Zhishu [1 ]
Yu, Ailing [1 ]
Shi, Hui [1 ]
Hu, Yuhan [1 ]
Jin, Bo [1 ]
Lin, Dan [1 ]
Dai, Mali [1 ]
Lei, Lei [1 ]
Li, Xingyi [1 ]
Wang, Yuqin [1 ]
机构
[1] Wenzhou Med Univ, Eye Hosp, Sch Ophthalmol & Optometry, Inst Biomed Engn, 270 Xueyuan Rd, Wenzhou 325027, Peoples R China
基金
中国国家自然科学基金;
关键词
Glycol chitosan/oxidized hyaluronic acid hydrogel film; Dual drug delivery; Ocular drug delivery; CHITOSAN; NANOPARTICLES; BIOCOMPATIBILITY; ANTITUMOR;
D O I
10.1016/j.ijbiomac.2020.11.214
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the present study, we fabricated a glycol chitosan/oxidized hyaluronic acid hydrogel film with promising potential for the dual ophthalmic delivery of dexamethasone (Dex) and levofloxacin (Lev). Utilizing different oxidation degrees of oxidized hyaluronic acid (OHA), several blank hydrogel films and Lev-loaded hydrogel films were successfully fabricated. With an increase in the oxidation degree of OHA, the swelling ratio of the hydrogel films decreased accordingly. The hydrogel films displayed a stepwise release of Lev and Dex, with Lev rapidly released from the hydrogel film, followed by a sustained release of Dex. Lev-loaded hydrogel films revealed a potent capacity to inhibit bacterial growth in different bacterial strains. In lipopolysaccharide-activated RAW264.7 macrophages, the formulated hydrogel films displayed potent in vitro anti-inflammatory activity by significantly various inflammatory cytokines. Overall, the fabricated hydrogel film acting as a dual drug delivery system might be a promising vehicle for the treatment of postoperative endophthalmitis. (C) 2020 Elsevier B.V. All rights reserved.
引用
收藏
页码:659 / 666
页数:8
相关论文
共 47 条
  • [1] Ophthalmic gels: Past, present and future
    Al-Kinani, Ali A.
    Zidan, Ghada
    Elsaid, Naba
    Seyfoddin, Ali
    Alani, Adam W. G.
    Alany, Raid G.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2018, 126 : 113 - 126
  • [2] Designing lipid nanoparticles for topical ocular drug delivery
    Alvarez-Trabado, Jesus
    Diebold, Yolanda
    Sanchez, Alejandro
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 532 (01) : 204 - 217
  • [3] Bandi F, 2020, EUR ARCH OTO-RHINO-L, P1
  • [4] A Facile Strategy to Generate High Drug Payload Celecoxib Micelles for Enhanced Corneal Permeability
    Bao, Zhishu
    Zhou, Yanfang
    Lei, Lei
    Zhang, Renshu
    Song, Qianqian
    Li, Xingyi
    Wang, Yuqin
    [J]. JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2019, 15 (04) : 822 - 829
  • [5] Bukhari SNA, 2018, INT J BIOL MACROMOL, V120, P1682, DOI [10.1016/j.ijbiomac.2018.09.188, 10.1016/j.fibiomac.2018.09.188]
  • [6] The prominence of the dosage form design to treat ocular diseases
    Campos, Patricia Mazureki
    Petrilli, Raquel
    Lopez, Renata F., V
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2020, 586
  • [7] Recent developments in ocular drug delivery
    Chen, Hongming
    [J]. JOURNAL OF DRUG TARGETING, 2015, 23 (7-8) : 597 - 604
  • [8] Collagen/chitosan film containing biotinylated glycol chitosan nanoparticles for localized drug delivery
    Chen, Ming-Mao
    Huang, Yu-Qing
    Cao, Huan
    Liu, Yan
    Guo, Hao
    Chen, Lillian S.
    Wang, Jian-Hua
    Zhang, Qi-Qing
    [J]. COLLOIDS AND SURFACES B-BIOINTERFACES, 2015, 128 : 339 - 346
  • [9] Sustained release of levofloxacin from thermosensitive chitosan-based hydrogel for the treatment of postoperative endophthalmitis
    Cheng, Yung-Hsin
    Chang, Yu-Fan
    Ko, Yu-Chieh
    Liu, Catherine Jui-Ling
    [J]. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS, 2020, 108 (01) : 8 - 13
  • [10] Management of bacterial postoperative endophthalmitis and the role of vitrectomy
    Clarke, Ben
    Williamson, Thomas H.
    Gini, Giampaolo
    Gupta, Bhaskar
    [J]. SURVEY OF OPHTHALMOLOGY, 2018, 63 (05) : 677 - 693